Premium
Cartilage‐specific autoimmunity in rheumatoid arthritis: characterization of a triple helical B cell epitope in the integrin‐binding‐domain of collagen type II
Author(s) -
Kraetsch HansGeorg,
Unger Christine,
Wernhoff Patrik,
Schneider Christian,
Kalden Joachim R.,
Holmdahl Rikard,
Burkhardt Harald
Publication year - 2001
Publication title -
european journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.272
H-Index - 201
eISSN - 1521-4141
pISSN - 0014-2980
DOI - 10.1002/1521-4141(200106)31:6<1666::aid-immu1666>3.0.co;2-t
Subject(s) - epitope , autoantibody , monoclonal antibody , type ii collagen , integrin , epitope mapping , immune system , autoimmunity , biology , linear epitope , antibody , microbiology and biotechnology , arthritis , rheumatoid arthritis , immunology , biochemistry , cell
Abstract Cartilage‐specific proteins are considered potential autoantigens that could continuously fuel autoimmune responses directed to the joints in rheumatoid arthritis (RA). Using recombinant chimeric collagen type II we have identified one major type II collagen (CII) epitope (denoted U1) recognized by RA sera. The U1 epitope is a triple helical structure formed by 11 amino acids (triple helical position 494–504) and colocalizes with the recently described α1β1/α2β1 integrin binding site. It is a major epitope, found in 14/22 RA sera positive for antibodies to CII. One individual could be followed for a long time and the results showed that IgG antibodies specific for the U1 epitope were maintained along the chronic disease course but suppressed during periods of cyclosporin A and anti‐CD4 treatment. We also found that the U1 epitope was recognized in rats susceptible to collagen‐induced arthritis. A monoclonal autoantibody (mAb 126.30) was raised from DA rats, which bound the same epitope. The antibodies bound the cartilage in vivo showing that the epitope is exposed to the immune system for immune complex formation in the intact joint.